OnCo
ideasIdea

A dedicated global financing window for cancer, modelled on the Global Fund

Cancer kills more people in poorer countries than HIV, TB and malaria combined, but has no global fund. A pooled fund for diagnosis, essential medicines and radiotherapy would change what ministries can afford to build.

Development assistance for health has largely bypassed cancer. Despite rising burden in LMICs, there is no multilateral financing instrument for cancer services comparable to the Global Fund or Gavi. A financing window, whether a new fund or a cancer envelope inside an existing one, would co-finance national cancer control plans with conditions on registries, essential medicine availability, and palliative care. The design questions are governance, co-financing ratios, and how to avoid crowding out domestic spending.

Hypothesis
Countries receiving co-financing tied to a costed national cancer plan will increase the proportion of patients receiving any cancer treatment by at least 50% within six years, measured through population-based registries.
Rationale
The Global Fund and Gavi showed that predictable, results-linked external finance plus technical assistance builds durable programmes; cancer control has the same structure of high fixed costs and long payback.
What would test it
A five-country pilot envelope with published disbursements, registry-based outcome tracking, and an independent evaluation against matched non-recipient countries.
Maturity
speculative
Who has to act
policy
Cost to try
Large (over $50M)
Years to first evidence
6
Bottlenecks it attacks

Connected

4top

Pages like this

not linked directly; found by shared links